Mark J. Fitzpatrick
Director/Board Member at ALLENA PHARMACEUTICALS, INC.
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Alexey L. Margolin | M | 71 | 13 years | |
| Vincent Forster | M | - |
Versantis AG
 Versantis AG BiotechnologyHealth Technology Versantis AG develops liver disease therapeutics and diagnostics. Its pipeline include VS-01, a drug to support liver, brain, and kidneys; VS-02 and VS-03 that are solutions for chronic liver diseases and treatment of drug intoxications; and other products for the treatment of metabolic academia and diagnosis of hyperammonemia. The company was founded by Vincent Forster and Meriam Kabbaj in 2015 and is headquartered in Zurich, Switzerland. | 9 years |
| Meriam Kabbaj | M | 50 |
Versantis AG
Versantis AG BiotechnologyHealth Technology Versantis AG develops liver disease therapeutics and diagnostics. Its pipeline include VS-01, a drug to support liver, brain, and kidneys; VS-02 and VS-03 that are solutions for chronic liver diseases and treatment of drug intoxications; and other products for the treatment of metabolic academia and diagnosis of hyperammonemia. The company was founded by Vincent Forster and Meriam Kabbaj in 2015 and is headquartered in Zurich, Switzerland. | 9 years |
| Geoffrey A. Swire | M | - | 6 years | |
| Ann Miller | M | 66 | 4 years | |
| Robert Schier | M | - |
Versantis AG
Versantis AG BiotechnologyHealth Technology Versantis AG develops liver disease therapeutics and diagnostics. Its pipeline include VS-01, a drug to support liver, brain, and kidneys; VS-02 and VS-03 that are solutions for chronic liver diseases and treatment of drug intoxications; and other products for the treatment of metabolic academia and diagnosis of hyperammonemia. The company was founded by Vincent Forster and Meriam Kabbaj in 2015 and is headquartered in Zurich, Switzerland. | - |
| Peter Nicklin | M | 61 |
Versantis AG
Versantis AG BiotechnologyHealth Technology Versantis AG develops liver disease therapeutics and diagnostics. Its pipeline include VS-01, a drug to support liver, brain, and kidneys; VS-02 and VS-03 that are solutions for chronic liver diseases and treatment of drug intoxications; and other products for the treatment of metabolic academia and diagnosis of hyperammonemia. The company was founded by Vincent Forster and Meriam Kabbaj in 2015 and is headquartered in Zurich, Switzerland. | - |
| Michael Sidler | M | 55 |
Versantis AG
Versantis AG BiotechnologyHealth Technology Versantis AG develops liver disease therapeutics and diagnostics. Its pipeline include VS-01, a drug to support liver, brain, and kidneys; VS-02 and VS-03 that are solutions for chronic liver diseases and treatment of drug intoxications; and other products for the treatment of metabolic academia and diagnosis of hyperammonemia. The company was founded by Vincent Forster and Meriam Kabbaj in 2015 and is headquartered in Zurich, Switzerland. | - |
| Christopher R. Seaton | M | - |
Versantis AG
Versantis AG BiotechnologyHealth Technology Versantis AG develops liver disease therapeutics and diagnostics. Its pipeline include VS-01, a drug to support liver, brain, and kidneys; VS-02 and VS-03 that are solutions for chronic liver diseases and treatment of drug intoxications; and other products for the treatment of metabolic academia and diagnosis of hyperammonemia. The company was founded by Vincent Forster and Meriam Kabbaj in 2015 and is headquartered in Zurich, Switzerland. | - |
| Hugh Wight | M | - | - | |
| Matthew Foster | M | - | 2 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Gregory D. Phelps | M | 75 |
RenaMed Biologics, Inc.
 RenaMed Biologics, Inc. Medical/Nursing ServicesHealth Services RenaMed Biologics, Inc. provided clinical cellular therapy. The company was founded by H. David Humes, James P. Sherblom and Richard A. Andrews in 1995 and was headquartered in Lincoln, RI. | 12 years |
| Louis Brenner | M | 54 | 7 years | |
| Rajkumar Kannan | M | 61 | 2 years | |
| Sandy Smith | M | 77 | 4 years | |
| Mark Leuchtenberger | M | 67 | 1 years | |
| Paul Thomas | M | 68 | 5 years | |
| Mark A. Nowak | M | - |
Boston College
| 7 years |
| Karl B. Thor | M | - |
Dynogen Pharmaceuticals, Inc.
 Dynogen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Dynogen Pharmaceuticals, Inc. develops and manufactures drugs. The company makes drugs for genitourinary and gastrointestinal disorders. It also makes drugs for constipation, Irritable Bowel Syndrome and overactive bladder. Dynogen Pharmaceuticals was founded by Lee R. Brettman in 2002 and is located in Waltham, MA. | - |
| Chaime Orlev | M | 53 | 6 years | |
| Jonathan M. Albano | M | - |
Boston College
| 7 years |
| David J. Aubuchon | M | - | - | |
| Jason Fredette | M | - | 1 years | |
| Scott A. Holmes | M | 50 |
Dynogen Pharmaceuticals, Inc.
Dynogen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Dynogen Pharmaceuticals, Inc. develops and manufactures drugs. The company makes drugs for genitourinary and gastrointestinal disorders. It also makes drugs for constipation, Irritable Bowel Syndrome and overactive bladder. Dynogen Pharmaceuticals was founded by Lee R. Brettman in 2002 and is located in Waltham, MA. | - |
| William P. Whitaker | M | - | 8 years | |
| Alison Kiley | F | 51 | 7 years | |
| Brian A. Murphy | M | - |
Boston College
| 4 years |
| Allene Diaz | F | 59 | 3 years | |
| Daniel Gottlieb | M | 53 | - | |
| Dror Brandwein | M | - | 3 years | |
| William T. Andrews | M | 60 | 4 years | |
| Anand Varadan | M | 57 | 3 years | |
| Ben Harshbarger | M | 55 | 4 years | |
| Tara Mccarthy | F | 50 | - | |
| Dawn Schottlandt | F | - | 1 years | |
| Drew Enamait | M | 50 | 6 years | |
| lee Giguere | M | 43 | 2 years | |
| John Doyle | M | 46 | - | |
| Lee R. Brettman | M | 77 |
Dynogen Pharmaceuticals, Inc.
Dynogen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Dynogen Pharmaceuticals, Inc. develops and manufactures drugs. The company makes drugs for genitourinary and gastrointestinal disorders. It also makes drugs for constipation, Irritable Bowel Syndrome and overactive bladder. Dynogen Pharmaceuticals was founded by Lee R. Brettman in 2002 and is located in Waltham, MA. | 7 years |
| Andrew Hack | M | 50 | 3 years | |
| Ansbert Gadicke | M | 66 | 2 years | |
| Christine Pellizzari | F | 56 | 5 years | |
| Anne VanLent | F | 76 | 3 years | |
| John Thero | M | 63 | 6 years | |
| James Tobin | M | 79 | 1 years | |
| Sol Barer | M | 76 | 5 years | |
| Jorge Plutzky | M | 65 | 1 years | |
| Anne Cook | F | 62 | 4 years | |
| Vincent J. Miles | M | 73 | 3 years | |
| Theodore Ashburn | M | 57 |
Dynogen Pharmaceuticals, Inc.
Dynogen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Dynogen Pharmaceuticals, Inc. develops and manufactures drugs. The company makes drugs for genitourinary and gastrointestinal disorders. It also makes drugs for constipation, Irritable Bowel Syndrome and overactive bladder. Dynogen Pharmaceuticals was founded by Lee R. Brettman in 2002 and is located in Waltham, MA. | - |
| James Topper | M | 62 | 10 years | |
| Robert Alexander | M | 54 | 6 years | |
| Kevin Kerrigan | M | - |
Diacrin, Inc. (Delaware)
 Diacrin, Inc. (Delaware) Medical SpecialtiesHealth Technology Diacrin, Inc. develops human cell transplant therapeutic products. The company is headquartered in Wilmington, DE. | 6 years |
| Michael P. Malloy | M | 64 |
Boston College
| 7 years |
| John Sullivan | M | 65 |
Boston College
| 6 years |
| William John Cohane | M | - |
Boston College
| 4 years |
| Christine McGrath | F | 58 |
Boston College
| 4 years |
| Guy V. Amoresano | M | - |
Boston College
| 3 years |
| Philip Schiller | M | 63 |
Boston College
| 4 years |
| W. Heavey | M | - |
Boston College
| 4 years |
| Yao Chee Wong | M | 78 |
Boston College
| 2 years |
| Joe Callanan | M | - |
Boston College
| 4 years |
| Frances K. Blanco | F | - |
Boston College
| 2 years |
| Anthony M. Mattioli | M | 65 |
Boston College
| 4 years |
| Makelín Arias Boyd | F | 59 |
Boston College
| 4 years |
| Erik S. Brown | M | - |
Boston College
| 4 years |
| Patrick Tyrrell | M | 63 |
Boston College
| 4 years |
| Frank Strauss | M | - |
Boston College
| 5 years |
| Scott Kerslake | M | - |
Boston College
| 4 years |
| Amy Seigenthaler | F | - |
Boston College
| 4 years |
| Joe Schreiber | M | - |
Boston College
| 4 years |
| Ann L. Milner | F | - |
Boston College
| 3 years |
| Bill P. Morrissey | M | 59 |
Boston College
| 4 years |
| Tom G. Rock | M | - |
Boston College
| 3 years |
| David E. Wezdenko | M | 60 |
Boston College
| 4 years |
| Jamie Patrick Linkowski | M | - |
Boston College
| 4 years |
| Ettore A. Santucci | M | - |
Boston College
| 3 years |
| Nick Gendron | M | - |
Boston College
| 4 years |
| Charles Thomas Cameron | M | - |
Boston College
| 4 years |
| Jeremiah T. Doyle | M | - |
Boston College
| 4 years |
| James D. Herschlein | M | - |
Boston College
| 4 years |
| Steven J. Musumeci | M | - |
Boston College
| 4 years |
| Doug Shamon | M | - |
Boston College
| 4 years |
| Philip Richard Acinapuro | M | 64 |
Boston College
| 3 years |
| Catherine Vaczy | F | 62 |
Boston College
| 4 years |
| Jonathan H. Dinsmore | M | - |
Boston College
| 4 years |
| Christina Callahan | F | - |
Boston College
| 4 years |
| James L. Bromley | M | - |
Boston College
| 4 years |
| Debra Wong Yang | F | - |
Boston College
| 3 years |
| Robert M. Berry | M | - |
Boston College
| 4 years |
| David Cobey | M | - |
Boston College
| 4 years |
| Diane Englert Christian | F | - |
Boston College
| 4 years |
| Jonathan B. Abram | M | - |
Boston College
| 3 years |
| Robert Downs Cresci | M | - |
Boston College
| 4 years |
| Bettina Doulton | F | - |
Boston College
| 4 years |
| John J. Concannon | M | - |
Boston College
| 4 years |
| Jim Aylward | M | - |
Boston College
| 4 years |
| Kim Keck | F | 60 |
Boston College
| 4 years |
| John Warren | M | - |
Boston College
| 4 years |
| Brian W Steel | M | - |
Boston College
| 3 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 94 | 94.00% |
| Switzerland | 6 | 6.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Mark J. Fitzpatrick
- Personal Network
